MedTrace Logo

Evaluation of a New Cardiac Pacemaker

NCT01700244 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2013-06-26

No results posted yet for this study

Summary

An evaluation of a safety and performance of a new cardiac pacemaker

Conditions

  • Atrial Fibrillation With 2 or 3° AV or Bifascicular Bundle Branch (BBB) Block
  • Normal Sinus Rhythm With 2 or 3° AV or BBB Block
  • Sinus Bradycardia With Infrequent Pauses or Unexplained Syncope With EP Findings

Interventions

DEVICE

Pacemaker implant

Sponsors & Collaborators

  • Nanostim, Inc.

    lead INDUSTRY

Principal Investigators

  • Johannes Sperzel, MD · Kerckhoff Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-07-31
Completion
2013-08-31

Countries

  • Czechia
  • Germany
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01700244 on ClinicalTrials.gov